We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
American Oriental Bioengineering, Inc., an emerging Chinese manufacturer and distributor of plant-based pharmaceutical and nutraceutical products, today announced financial results for the first quarter ending March 31, 2006.
Israel-based Allergica has entered into an agreement with the Lovelace Respiratory Research Institute (LRRI) to develop an inhaleable version of its antihistamine drug, the company reported.
The FDA has approved a stop-smoking drug by Pfizer that satisfies nicotine cravings and diminishes the satisfaction of smoking to prevent relapse, the agency reported.
The U.S. International Trade Commission (ITC) plans to investigate Amgen's claim that Swiss drugmaker Roche's importation of the anemia drug Cera violates Amgen's patents on its anemia treatment Epogen, Amgen reported.
Japan-based Eisai has signed a joint research agreement with Nitto Denko to develop a transdermal formulation of Aricept, an agent for
treating Alzheimer's disease.
The High Court in the UK has granted an injunction to protect GlaxoSmithKline (GSK) shareholders against the recent threat posed by animal extremists, who contacted investors by mail warning them to sell their shares in the company.